NASDAQ:ANTX

Anthem (ANTX) Stock Price, News & Analysis

Anthem logo
$4.12 -0.36 (-7.94%)
As of 12:32 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Anthem Stock (NASDAQ:ANTX)

Advanced

Key Stats

Today's Range
$3.92
▼
$4.60
50-Day Range
$3.37
▼
$5.98
52-Week Range
$1.00
▼
$7.19
Volume
75,560 shs
Average Volume
584,045 shs
Market Capitalization
$156.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.00
Consensus Rating
Hold

Company Overview

Anthem, Inc. was a U.S. health benefits company that provided health insurance and related services to individuals, employers, and government-sponsored programs. Its offerings included medical, dental, and vision coverage, pharmacy benefits, and plans serving Medicare and Medicaid members.

The company operated health plans across the United States, including plans affiliated with the Blue Cross Blue Shield network. In 2022, Anthem changed its corporate name to Elevance Health to reflect a broader focus on health services beyond insurance.

The ticker in the request appears to be incorrect: Anthem historically traded as ANTM, and Elevance Health trades as ELV on the New York Stock Exchange. ANTX is not Anthem’s ticker.

AI Generated. May Contain Errors.

Anthem Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
57th Percentile Overall Score

ANTX MarketRank™: 
2.85942279558 of 5 stars

Anthem scored higher than 57% of companies evaluated by MarketBeat, and ranked 424th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Anthem has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    Anthem has a consensus price target of $9.00, representing about 101.3% upside from its current price of $4.47.

  • Amount of Analyst Coverage

    Anthem has only been the subject of 1 research reports in the past 90 days.

  • Read more about Anthem's stock forecast and price target.
  • Price to Book Value per Share Ratio

    Anthem has a P/B Ratio of 2.25. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    8.36% of the float of Anthem has been sold short.
  • Short Interest Ratio / Days to Cover

    Anthem has a short interest ratio ("days to cover") of 9.18.
  • Change versus previous month

    Short interest in Anthem has recently decreased by 15.49%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Anthem does not currently pay a dividend.

  • Dividend Growth

    Anthem does not have a long track record of dividend growth.

  • News Sentiment

    Anthem has a news sentiment score of 1.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Anthem this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Anthem insiders have sold 2,746.12% more of their company's stock than they have bought. Specifically, they have bought $11,602.00 in company stock and sold $330,207.00 in company stock.

  • Percentage Held by Insiders

    22.61% of the stock of Anthem is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    90.47% of the stock of Anthem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Anthem's insider trading history.
Receive ANTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Anthem and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ANTX Stock News Headlines

Your Copy is on Hold (Claim it now)
James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on Elon Musk's next big industry play. He estimates it could create 1.8 million new millionaires in the coming years, and shows how to position in the company at its center for under $60. Inside: the company's name and ticker, plus an FCC filing James believes reveals Elon's plan to take over a $25 trillion industry. He also flags December 8 as a key date.tc pixel
See More Headlines

ANTX Stock Analysis - Frequently Asked Questions

Anthem's stock was trading at $1.13 at the start of the year. Since then, ANTX stock has increased by 295.6% and is now trading at $4.47.

Anthem, Inc. (NASDAQ:ANTX) released its quarterly earnings data on Monday, November, 9th. The company reported ($0.17) earnings per share for the quarter.

Anthem (ANTX) raised $69 million in an IPO on Wednesday, March 23rd 2022. The company issued 4,600,000 shares at $14.00-$16.00 per share.

Top institutional shareholders of Anthem include Goldman Sachs Group Inc. (1.67%), State Street Corp (1.18%), Russell Investments Group Ltd. (0.59%) and Marshall Wace LLP (0.28%). Insiders that own company stock include Braden Michael Leonard, Global Health Technol Adjuvant, Eric Easom, Robin Shane Readnour, Kabeer Aziz, Ra Capital Management, LP, Joshua M Eizen, Sanjay Chanda, Lucy Day, Sarah Joanne Williams, Stephen David Prior, Margaret M Fitzpatrick and Kevin Michael Krause.
View institutional ownership trends
.

Shares of ANTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/09/2026
Today
11/17/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:ANTX
Previous Symbol
NASDAQ:ANTX
CIK
1156093
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$9.00
Low Price Target
$9.00
Potential Upside/Downside
+119.0%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.93)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$35.17 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-48.74%
Return on Assets
-44.56%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
10.48
Quick Ratio
14.32

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.99 per share
Price / Book
2.07

Miscellaneous

Outstanding Shares
37,940,000
Free Float
29,365,000
Market Cap
$155.93 million
Optionable
Optionable
Beta
-0.93
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

This page (NASDAQ:ANTX) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners